Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
Status:
Active, not recruiting
Trial end date:
2025-05-07
Target enrollment:
Participant gender:
Summary
The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD),
pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19
postural orthostatic.